Joada Best
Psychiatric/Mental Health · Sioux City, IANPI 1619153137
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations.
Across 288 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$558
- AbbVie$491
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$455
- Johnson & Johnson$434
- Supernus Pharmaceuticals, Inc.$411
- Corium, LLC$331
- plus $2K from 16 others
What the payments were for
- Food & beverage$4,20797%
- Education$1433%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 36 | $558 |
| AbbVie | 32 | $491 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $455 |
| Johnson & Johnson | 27 | $434 |
| Supernus Pharmaceuticals, Inc. | 29 | $411 |
| Corium, LLC | 29 | $331 |
| Neurocrine Biosciences, Inc. | 21 | $292 |
| Teva Pharmaceuticals USA, Inc. | 13 | $286 |
| Lundbeck LLC | 13 | $206 |
| Otsuka America Pharmaceutical, Inc. | 12 | $192 |
| Vanda Pharmaceuticals Inc. | 8 | $159 |
| Collegium Pharmaceutical, Inc. | 15 | $147 |
| Ironshore Pharmaceuticals Inc. | 8 | $116 |
| Tris Pharma Inc | 2 | $48 |
| Insulet Corporation | 1 | $45 |
| Indivior Inc. | 3 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$214
- INVEGA SUSTENNA$109
How this compares
$4,350 in reported general payments places this provider in the 85th percentile of 443 psychiatric/mental health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 11 | $2,857 |
| Naltrexone Hcl | 18 | $537 |
| Sertraline Hcl | 20 | $91 |
| Topiramate | 14 | $69 |
| Clonidine Hcl | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Sioux City
- Melissa KonkenSioux City$14K
- Ricardo OsorioSioux City$8K
- Brenda CainSioux City$6K
- Danika HansenSioux City$5K
- Erin HodgsonSioux City$4K
- Tyler LeskoSioux City$4K
- Cynthia GuthmillerSioux City$4K
- Monica NuckollsSioux City$4K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.